Office-based treatment for opioid dependence: reaching new patient populations.
about
Treatment Outcome Comparison Between Telepsychiatry and Face-to-face Buprenorphine Medication-assisted Treatment for Opioid Use Disorder: A 2-Year Retrospective Data Analysis.Provision of ancillary medications during buprenorphine detoxification does not improve treatment outcomesFactors affecting willingness to provide buprenorphine treatment.HIV/AIDS and drug use in China--interactions, impacts, and issues.Buprenorphine for opioid dependenceBuprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review.Barriers to use of pharmacotherapy for addiction disorders and how to overcome them.HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy.Treating opioid addiction with buprenorphine-naloxone in community-based primary care settingsParticipant characteristics and buprenorphine dose.To Be Free and Normal: Addiction, Governance, and the Therapeutics of BuprenorphineInitiation of buprenorphine during incarceration and retention in treatment upon release.Selective review and commentary on emerging pharmacotherapies for opioid addiction.Comparison of behavioral treatment conditions in buprenorphine maintenance.Heroin anticraving medications: a systematic review.Factors associated with non-adherence to Buprenorphine-naloxone among opioid dependent African-Americans: A retrospective chart review.Buprenorphine/Naloxone Maintenance Therapy: an Observational Retrospective Report on the Effect of Dose on 18 months Retention in an Office-Based Treatment Program.Primary care models for treating opioid use disorders: What actually works? A systematic reviewMySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot study
P2860
Q31155610-7D5E21B8-C437-4B00-B066-3408744B42ECQ33795318-31046A3B-CFB5-41F8-8715-1885EDE095BBQ33836333-53A88D5F-6A58-45AD-A165-229F7615CC24Q34119447-02E07454-F1E7-4CDE-840A-A9FA8855E7F4Q34119459-C40E0C24-37C3-4B28-B450-617982522093Q35160035-C2C87976-0746-4FA9-85BF-38E0391B41A6Q35490468-EE322A07-272A-44AB-971B-F1915DA72656Q35686969-A9A1EBE3-24EE-4103-8ED5-0B9B2CA745E9Q35687716-D7AD7BBB-21D5-41CA-A810-EA353C75921CQ35721931-8FD886DE-7CBE-4964-AFFD-D6C1077FD338Q35738688-682B8DD1-0FC9-4A5F-82BB-2EB73675680DQ36399916-932C4CCB-105A-46DF-A821-E724702EF5F4Q36948204-5B28D500-DE8C-4E95-9CB9-4D30FD690BF1Q37355286-01E92F46-0C8B-41A3-AE4D-D504825FC7EBQ37400852-EF2DC88F-E11B-4488-888E-FAB5686E9B5DQ37800930-A39CA149-5FE8-43AF-B89E-8103EF18A0F3Q38691415-51575CC2-EA1A-42FE-861B-6FEC4C436CE7Q42375619-040A9D2B-0543-4430-A009-C23539C72239Q42656779-30724E58-8175-4C20-B98F-E7BE0BE92E92Q58700874-DDDB2A08-0718-4A3D-88BE-F48E04F6804B
P2860
Office-based treatment for opioid dependence: reaching new patient populations.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Office-based treatment for opioid dependence: reaching new patient populations.
@en
Office-based treatment for opioid dependence: reaching new patient populations.
@nl
type
label
Office-based treatment for opioid dependence: reaching new patient populations.
@en
Office-based treatment for opioid dependence: reaching new patient populations.
@nl
prefLabel
Office-based treatment for opioid dependence: reaching new patient populations.
@en
Office-based treatment for opioid dependence: reaching new patient populations.
@nl
P1476
Office-based treatment for opioid dependence: reaching new patient populations.
@en
P2093
Rosenheck RA
P304
P356
10.1176/APPI.AJP.158.8.1200
P407
P577
2001-08-01T00:00:00Z